PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges as they…
New Survey Reveals 84% of Payers Prioritize Total Cost Management as Cell and Gene Therapies Present Unprecedented Challenges DALLAS, TX – Employers and health plans…
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
Understand Considerations for OptumRx’s PA Announcement OptumRx (Optum) recently announced significant changes to its prior authorization program, eliminating the reauthorization process for 80 drugs…
Proactive Pharmacy Benefit Oversight in an Evolving Legal Landscape In the first quarter of 2025, plan fiduciaries witnessed significant news about and movement on pharmacy…
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
As a health plan pharmacy leader, you steward millions if not billions in annual pharmacy spend. Yet, as you know, translating complex Pharmacy Benefit Manager…
Leverage Integrated Data to Inform Better Benefit Decisions Migraines are more than just headaches, they’re a significant health challenge affecting millions of Americans, with…
